German Social Association slams proposed healthcare co-payment hikes as unfair
German Social Association slams proposed healthcare co-payment hikes as unfair
Rising Costs for Medications and Hospital Stays
German Social Association slams proposed healthcare co-payment hikes as unfair
Düsseldorf – The North Rhine-Westphalia branch of the German Social Association (VdK NRW) has sharply criticized plans to increase co-payments for prescription medications and hospital stays. "The proposed hikes—from €5–10 to €7.50–15—represent an unreasonable burden on patients, especially older adults, retirees, and those with chronic illnesses who often rely on multiple daily medications," said the association's president, Horst Vöge.
The organization warns of deepening social inequality in healthcare. Many are already struggling under the weight of rising living costs, and additional out-of-pocket expenses risk making essential medical care dependent on financial means. "This is the wrong approach," Vöge emphasized. "Health must not become a matter of affordability. There is a real danger that people will skip vital medications due to cost, putting their health at risk." The VdK NRW is calling on the federal government to immediately abandon these plans and instead ensure high-quality care without further straining insured individuals.
From the association's perspective, the state must first fulfill its obligations by fully and immediately covering contributions for citizens receiving basic welfare benefits. "We're talking about €12 billion that has so far been paid by insured individuals—92 percent of the population," Vöge noted.
German nursing care reform faces backlash over financial risks ahead of cabinet review
A €1.8 billion annual burden on pensions. Half of care home residents at risk of welfare. Why Germany's reform is under fire—and what happens next.
Region transforms healthcare with new hospitals and modernized rural clinics
From high-tech hospitals to rural clinic revamps, this region is rewriting its healthcare story. Thousands of patients will soon benefit from expanded access and cutting-edge facilities.
FDA panel with industry ties to review peptide injection safety in July
A controversial FDA panel, stacked with doctors profiting from peptides, will decide their fate. Will science or business interests shape the outcome?
Nursing homes in crisis as low wages spark staffing shortages and delays
Thousands wait for care as underpaid staff push nursing homes to the brink. Will strikes force a pay rise—or collapse the system further?